文献速递围术期管理与 ERAS急腹症与外科感染

结构化审查流程促进外科创新并提升患者安全

Facilitation of Surgical Innovation: Is It Possible to Speed the Introduction of New Technology While Simultaneously Improving Patient Safety?
PubMed 文献 · Ann Surg · 2019-01-01

该研究在大型四级肿瘤中心建立由外科质量官和围术期护士组成的持续质量改进团队(CQIT),对拟引入的新器械与新术式进行结构化审查,并比较实施前后的审批效率与患者安全数据。结果显示审批与试验等待时间均缩短,器械相关并发症率由10%降至0%,经CQIT批准并模拟演练的新术式无并发症。

要点

  • 设立外科质量官主导的结构化审查可缩短新器械审批时间
  • 结构化审查后器械相关并发症率由10%降至0%
  • 经模拟演练批准的新术式未出现并发症

核心结论

  • 在手术创新评估流程中加入专职外科质量官团队,可同时提高新器械和新术式引入的效率和安全性。

研究设计与样本

  • 在大型四级肿瘤中心建立持续质量改进团队(CQIT),由外科质量官和围术期护士对拟引入的新器械与新术式进行结构化审查。
  • 比较CQIT实施前后的审批效率指标与患者安全数据,并由CQIT审查7项新术式。

主要发现

  • 总平均评估时间由124天降至51天(P=0.007)。
  • 需术中试用的新器械从提案到试用的时间由平均260天降至99天(P=0.014)。
  • CQIT实施前器械相关并发症率为10%,实施后为0%。
  • 两项绕过CQIT审查的器械出现轻微和严重并发症,包括一例死亡;经CQIT批准并模拟演练的5项新术式无并发症。

临床怎么用

  • 对新器械与新术式引入设置结构化前置审查,并由外科质量官与围术期护士组成专职团队执行。
  • 避免器械或术式行政性绕过结构化审查流程。

局限性

  • 原文未报告研究设计的随机化或盲法信息,无法从此摘要判断因果推断强度。
  • 原文未报告样本量计算方法、置信区间及除P值外的统计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review efficiency metrics and patient safety data before and after implementation of a structured review process for surgical innovations. SUMMARY BACKGROUND DATA: Surgical innovation ranges from minor incremental improvement to radical experimentation. Although innovation paradigms have been described, these are not widely adopted or enforced in the surgical community. METHODS: A Continuous Quality Improvement Team (CQIT) of surgical quality officers and perioperative nurses was organized to perform structured reviews of proposed new surgical devices and procedures at a large quaternary cancer care center. The CQIT process was placed to precede an established Value Analysis Team business evaluation. Pre- and post-CQIT implementation metrics of approval process efficiency and patient safety data were compared. Seven novel procedures were also vetted by the CQIT. RESULTS: Forty-six product requests were evaluated after CQIT implementation. Compared with 34 products evaluated prior to CQIT establishment, the total mean evaluation time decreased from 124 to 51 days (P= 0.007). For new devices requiring intraoperative trial, the time between product proposal and trial decreased from a mean of 260 to 99 days (P= 0.014). The rate of device-related complications in the pre-CQIT group was 10% compared with 0% post-CQIT. Two devices, which administratively bypassed CQIT review, had both minor and major complications, including a mortality. Five novel procedures approved by CQIT with simulation were performed without complications. CONCLUSIONS: Using novel algorithms, the addition of a dedicated team of surgical quality officers to the surgical innovation evaluation process improved both the efficiency and the safety associated with introducing new devices and procedures into practice.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Marcus RK, Lillemoe HA, Caudle AS, et al. Facilitation of Surgical Innovation: Is It Possible to Speed the Introduction of New Technology While Simultaneously Improving Patient Safety? Ann Surg. 2019. PMID: 30946086. doi:10.1097/SLA.0000000000003290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。